Litcius/Paper detail

Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee

Yi Lin, Lugui Qiu, Saad Z. Usmani, Chng Wee Joo, Luciano J. Costa, Benjamin A. Derman, Juan Du, Hermann Einsele, Carlos Fernández de Larrea, Roman Hájek, P. Joy Ho, Efstathios Kastritis, Joaquín Martínez‐López, María‐Victoria Mateos, Joseph Mıkhael, Philippe Moreau, Chandramouli Nagarajan, Ajay K. Nooka, Michael O’Dwyer, Fredrik Schjesvold, Surbhi Sidana, Niels WCJ van de Donk, Katja Weisel, Sonja Zweegman, Noopur Raje, Paula Rodríguez‐Otero, Larry D. Anderson, Shaji Kumar, Tom Martin

2024The Lancet Oncology67 citationsDOIOpen Access PDF

Topics & Concepts

Multiple myelomaChimeric antigen receptorMedicineRefractory (planetary science)Clinical PracticeOncologyImmunotherapyImmunologyIntensive care medicineFamily medicineImmune systemBiologyAstrobiologyCAR-T cell therapy researchSafe Handling of Antineoplastic Drugs